Cargando…
A case of non-neutropenic invasive pulmonary aspergillosis under immune checkpoint inhibitor therapy for malignant melanoma
The patient was a 70-year-old man with diabetes mellitus, alcoholic liver disease and bronchial asthma treated with corticosteroid and long-acting β-agonist inhalants. He had also been treated with nivolumab for advanced malignant melanoma for two years with a partial response. He presented to our d...
Autores principales: | Uchida, Yoshinori, Shimamura, So, Ide, Shuichiro, Masuda, Kazuki, Saiki, Masafumi, Sogami, Yusuke, Ishihara, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918848/ https://www.ncbi.nlm.nih.gov/pubmed/35295913 http://dx.doi.org/10.1016/j.rmcr.2022.101627 |
Ejemplares similares
-
Dramatic response to alectinib in an
ALK
‐positive LCNEC patient with a poor performance status: A case report
por: Masuda, Kazuki, et al.
Publicado: (2021) -
Significant therapeutic effectiveness of durvalumab after chemoradiotherapy for a patient with post‐operative recurrent pulmonary pleomorphic carcinoma
por: Shimamura, So, et al.
Publicado: (2021) -
Myositis induced by durvalumab in a patient with non‐small cell lung cancer: A case report
por: Kobayashi, Miyuki, et al.
Publicado: (2020) -
Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients
por: Trof, R. J., et al.
Publicado: (2007) -
Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review
por: Bassetti, Matteo, et al.
Publicado: (2017)